Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
Volume 311, Issue 1, Pages C101-C115
Publisher
American Physiological Society
Online
2016-04-29
DOI
10.1152/ajpcell.00344.2015
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The histone deacetylase inhibitor butyrate improves metabolism and reduces muscle atrophy during aging
- (2015) Michael E. Walsh et al. AGING CELL
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- PGC-1αgene transfer improves muscle function in dystrophic muscle following prolonged disease progress
- (2015) Katrin Hollinger et al. EXPERIMENTAL PHYSIOLOGY
- PGC-1α overexpression by in vivo transfection attenuates mitochondrial deterioration of skeletal muscle caused by immobilization
- (2015) Chounghun Kang et al. FASEB JOURNAL
- Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia
- (2015) Yu-Chou Tseng et al. JNCI-Journal of the National Cancer Institute
- Butyrate prevents muscle atrophy after sciatic nerve crush
- (2015) Michael E. Walsh et al. MUSCLE & NERVE
- Muscle wasting in disease: molecular mechanisms and promising therapies
- (2015) Shenhav Cohen et al. NATURE REVIEWS DRUG DISCOVERY
- Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia
- (2015) Yu-Chou Tseng et al. JNCI-Journal of the National Cancer Institute
- Limited Effect of Chronic Valproic Acid Treatment in a Mouse Model of Machado-Joseph Disease
- (2015) Sofia Esteves et al. PLoS One
- HDAC6 contributes to pathological responses of heart and skeletal muscle to chronic angiotensin-II signaling
- (2014) Kimberly M. Demos-Davies et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- HDAC1 activates FoxO and is both sufficient and required for skeletal muscle atrophy
- (2014) A. W. Beharry et al. JOURNAL OF CELL SCIENCE
- PGC1-α over-expression prevents metabolic alterations and soleus muscle atrophy in hindlimb unloaded mice
- (2014) Jessica Cannavino et al. JOURNAL OF PHYSIOLOGY-LONDON
- Glycine administration attenuates skeletal muscle wasting in a mouse model of cancer cachexia
- (2013) Daniel J. Ham et al. CLINICAL NUTRITION
- Synergistic combination of valproic acid and oncolytic parvovirus H-1PV as a potential therapy against cervical and pancreatic carcinomas
- (2013) Junwei Li et al. EMBO Molecular Medicine
- A Positive Regulatory Domain in CCAAT/Enhancer Binding Protein β (C/EBPβ) Is Required for the Glucocorticoid-Mediated Displacement of Histone Deacetylase 1 (HDAC1) from theC/ebpα Promoter and Maximum Adipogenesis
- (2013) Houssein-Salem Abdou et al. ENDOCRINOLOGY
- Skeletal muscle glycoprotein 130's role in Lewis lung carcinoma–induced cachexia
- (2013) Melissa J. Puppa et al. FASEB JOURNAL
- Myostatin/activin pathway antagonism: Molecular basis and therapeutic potential
- (2013) H.Q. Han et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Muscle wasting in cancer
- (2013) N. Johns et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Transcriptional and Translational Regulation of C/EBPβ-HDAC1 Protein Complexes Controls Different Levels of p53, SIRT1, and PGC1α Proteins at the Early and Late Stages of Liver Cancer
- (2013) Jingling Jin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Valproic acid enhances Oct4 promoter activity through PI3K/Akt/mTOR pathway activated nuclear receptors
- (2013) Han Fang Teng et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Resistance after Chronic Application of the HDAC-Inhibitor Valproic Acid Is Associated with Elevated Akt Activation in Renal Cell Carcinoma In Vivo
- (2013) Eva Juengel et al. PLoS One
- miR-206 Represses Hypertrophy of Myogenic Cells but Not Muscle Fibers via Inhibition of HDAC4
- (2013) Catherine E. Winbanks et al. PLoS One
- Identification of atrogin-1-targeted proteins during the myostatin-induced skeletal muscle wasting
- (2012) Sudarsanareddy Lokireddy et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia
- (2012) Andrea Bonetto et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Myostatin is a novel tumoral factor that induces cancer cachexia
- (2012) Sudarsanareddy Lokireddy et al. BIOCHEMICAL JOURNAL
- Importance of functional and metabolic impairments in the characterization of the C-26 murine model of cancer cachexia
- (2012) K. T. Murphy et al. Disease Models & Mechanisms
- Acetylation and deacetylation—novel factors in muscle wasting
- (2012) Nima Alamdari et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- p38β MAPK upregulates atrogin1/MAFbx by specific phosphorylation of C/EBPβ
- (2012) Guohua Zhang et al. Skeletal Muscle
- Myostatin promotes the wasting of human myoblast cultures through promoting ubiquitin-proteasome pathway-mediated loss of sarcomeric proteins
- (2011) Sudarsanareddy Lokireddy et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- C/EBPβ mediates tumour-induced ubiquitin ligase atrogin1/MAFbx upregulation and muscle wasting
- (2011) Guohua Zhang et al. EMBO JOURNAL
- Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease
- (2011) Liping Zhang et al. FASEB JOURNAL
- Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy
- (2011) Sarah A. Reed et al. FASEB JOURNAL
- C/EBPβ regulates dexamethasone-induced muscle cell atrophy and expression of atrogin-1 and MuRF1
- (2011) Patricia Gonnella et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Retraction: Myostatin Induces Degradation of Sarcomeric Proteins through a Smad3 Signaling Mechanism During Skeletal Muscle Wasting
- (2011) Sudarsanareddy Lokireddy et al. MOLECULAR ENDOCRINOLOGY
- Unknown
- (2011) Silvia Consalvi et al. MOLECULAR MEDICINE
- Regulation of skeletal muscle growth by the IGF1-Akt/PKB pathway: insights from genetic models
- (2011) Stefano Schiaffino et al. Skeletal Muscle
- Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival
- (2010) Xiaolan Zhou et al. CELL
- Valproic Acid Activates the PI3K/Akt/mTOR Pathway in Muscle and Ameliorates Pathology in a Mouse Model of Duchenne Muscular Dystrophy
- (2009) Praveen B. Gurpur et al. AMERICAN JOURNAL OF PATHOLOGY
- Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size
- (2009) Anne Ulrike Trendelenburg et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Deacetylase Inhibitors Modulate the Myostatin/Follistatin Axis without Improving Cachexia in Tumor-Bearing Mice
- (2009) A. Bonetto et al. CURRENT CANCER DRUG TARGETS
- Myostatin Inhibition Enhances the Effects of Exercise on Performance and Metabolic Outcomes in Aged Mice
- (2009) N. K. LeBrasseur et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Mechanisms of Cancer Cachexia
- (2009) Michael J. Tisdale PHYSIOLOGICAL REVIEWS
- Inhibition of Atrogin-1/MAFbx Mediated MyoD Proteolysis Prevents Skeletal Muscle Atrophy In Vivo
- (2009) Julie Lagirand-Cantaloube et al. PLoS One
- Dose translation from animal to human studies revisited
- (2007) Shannon Reagan-Shaw et al. FASEB JOURNAL
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started